Frustratingly, over 100 published clinical trials in sepsis targeting microbial factors, cytokines (including anti-TNF-alpha and anti-IL-1 beta monoclonal antibodies), and blood coagulation regulators have thus far failed (73). This evidence concerns the gene IL1B and Sepsis.